 |
Articles: Drug/Product Alerts |
FDA Approves Drug for Gout Management
FDA Press Releases, 03/02/09
Free full text
CTI Focuses on Late-Stage Drug Approvals and Commercialization and Cuts Operating Costs: to Close Bresso Research Center
Cell Therapeutics, 03/02/09
Free full text
FDA Approves Genzyme's Synvisc-One for Osteoarthritis of the Knee
Genzyme, 02/27/09
Free full text
European Authorities Approve Larger-Scale Production of Genzyme's Myozyme
Genzyme, 02/27/09
Free full text
Lilly Gets Green Light to Sell Prasugrel in Europe
PharmExec, 02/26/09 Mylans Matrix Receives WHO Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor
Mylan, 02/26/09 Cocaine Alters Vesicular Dopamine Sequestration and Potassium-Stimulated Dopamine Release: The Role of D2 Receptor Activation
Journal of Pharmacology and Experimental Therapeutics, 02/25/09 Zila to Introduce ViziLite Plus in India
Zila, 02/25/09
Free full text
Medtronic Receives FDA HDE Approval to Commercialize the First Deep Brain Stimulation Therapy for a Psychiatric Indication in the United States
Medtronic, 02/20/09
Free full text
FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
Amgen, 02/19/09
Free full text
Illuminating Heavy Metals Testing
Pharmaceutical Technology, 02/19/09
Free full text
Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products
Journal of Pharmacy and Pharmacology, 02/18/09 Cardinal Health, FDA amend infusion pump consent decree
Cardinal Health, 02/18/09
Free full text
Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of leeding episodes in patients with hemophilia
Biologics: targets & therapy, 02/17/09
Evidence Based Medicine
Sandoz receives European Commission approval for biosimilar filgrastim
Novartis, 02/16/09
Free full text
Teva Announces Approval and Launch of Generic Imitrex Tablets
Teva Pharmaceutical Industries, 02/12/09
Free full text
Taro Receives FDA Approval for Levetiracetam Oral Solution
Taro Pharmaceuticals USA, 02/12/09
Free full text
Dronedarone: An antiarrhythmic agent for the management of atrial fibrillation and atrial flutter
Formulary, 02/11/09 FDA Pipeline preview, February 2009 (asenapine, certolizumab, olanzapine long-acting injection, ustekinumab, oritavancin, rotigotine, vigabatrin)
Formulary, 02/10/09 Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Amgen, 02/09/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
143 Available Pages
|
|
